Our INGRESS colleagues Mahmoud Hashim, Robert Bartsch, and Bart Heeg have just published a new paper (see link below) in the journal Value in Health where they evaluate the relationship between surrogate (PFS, ORR) and hard endpoints OS in advanced NSCLC studies that did not allow for crossover or reported balanced post-progression treatments. Very well done
On Sunday, August 20th, 2017 Ingress-health completed the annual Schwedenlauf with a team of four. Sabine, Samron, Svenja and Rouven ran 5 kilometers each through the historical town of Wismar. Samron finished the race strong within 23.15 minutes. We will be donating 5 € per finished kilometer to the “Stiftung Deutsche Kinderkrebshilfe” (German Cancer Association).